Self-management exacerbation action plans in patients with COPD and common comorbidities: the COPE-III study

Research output: ThesisPhD Thesis - Research external, graduation UTAcademic

249 Downloads (Pure)

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a chronic progressive lung disease with distressing exacerbations - acute deteriorations in respiratory health - that contribute to impaired quality of life and increased hospitalisations, mortality and healthcare costs. Frequently existing comorbid conditions in COPD, such as cardiovascular diseases, mental health issues, and diabetes, have an important impact on disease severity, hospital admission rate, and survival. These comorbidities share common risk factors with COPD and have overlap in symptoms. In COPD patients with the added complexity of comorbidities a “one size fits all” approach that focuses solely on COPD symptoms may be inadequate and could lead to the initiation of incorrect or delayed treatment.

Twenty-two studies were evaluated in a Cochrane review comparing the effectiveness of COPD self-management interventions including an action plan for acute exacerbations of COPD with usual care. We observed that self-management interventions including a COPD exacerbation action plan are associated with improvements in health-related quality of life and a lower probability of respiratory-related hospital admissions, without excess all-cause mortality.

We report the design of the COPE-III self-management intervention, that combines self-initiated patient-tailored action plans for COPD and comorbidities (chronic heart failure, ischemic heart disease, anxiety, depression, diabetes mellitus) with ongoing case-manager support. We demonstrate that our international multicenter randomised controlled trial is the first to test and confirm that patients with COPD and important comorbidities have better outcomes if they receive a self-management intervention that addresses their multiple conditions compared to usual care. Furthermore, we found two subscales for the Dutch Partners in Health (PIH) scale: 1) knowledge and coping; 2) recognition and management of symptoms, adherence to treatment. We recommend using these two subscale scores when assessing self-management in Dutch COPD patients.

In summary, our implications for future research and clinical practice are:
•consider the self-treatment of comorbidities in patient-tailored exacerbation action plans together with associated self-management training for patients with COPD and comorbidities;
•cautiously only using action plans together with self-management interventions;
•provide more detailed information regarding the delivered self-management intervention;
•identify patient characteristics that predict successful COPD self-management; and
•reach consensus on a final version of the Partners in Health scale.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • University of Twente
Supervisors/Advisors
  • van der Palen, Job J.A.M., Supervisor
  • Effing, T.W., Supervisor
Award date15 Sep 2017
Print ISBNs978-90-365-4373-6
Publication statusPublished - 15 Sep 2017

Fingerprint

Self Care
Chronic Obstructive Pulmonary Disease
Comorbidity
Disease Management
N-succinyl-1,2-dioleoylphosphatidylethanolamine
Health
Quality of Life
Mortality
Health Care Costs
Lung Diseases
Myocardial Ischemia
Disease Progression
Consensus
Diabetes Mellitus
Mental Health
Hospitalization
Cardiovascular Diseases
Therapeutics
Survival Rate
Anxiety

Cite this

@phdthesis{d66e06dde9f146bf9f7f52e922d21c31,
title = "Self-management exacerbation action plans in patients with COPD and common comorbidities: the COPE-III study",
abstract = "Chronic Obstructive Pulmonary Disease (COPD) is a chronic progressive lung disease with distressing exacerbations - acute deteriorations in respiratory health - that contribute to impaired quality of life and increased hospitalisations, mortality and healthcare costs. Frequently existing comorbid conditions in COPD, such as cardiovascular diseases, mental health issues, and diabetes, have an important impact on disease severity, hospital admission rate, and survival. These comorbidities share common risk factors with COPD and have overlap in symptoms. In COPD patients with the added complexity of comorbidities a “one size fits all” approach that focuses solely on COPD symptoms may be inadequate and could lead to the initiation of incorrect or delayed treatment. Twenty-two studies were evaluated in a Cochrane review comparing the effectiveness of COPD self-management interventions including an action plan for acute exacerbations of COPD with usual care. We observed that self-management interventions including a COPD exacerbation action plan are associated with improvements in health-related quality of life and a lower probability of respiratory-related hospital admissions, without excess all-cause mortality. We report the design of the COPE-III self-management intervention, that combines self-initiated patient-tailored action plans for COPD and comorbidities (chronic heart failure, ischemic heart disease, anxiety, depression, diabetes mellitus) with ongoing case-manager support. We demonstrate that our international multicenter randomised controlled trial is the first to test and confirm that patients with COPD and important comorbidities have better outcomes if they receive a self-management intervention that addresses their multiple conditions compared to usual care. Furthermore, we found two subscales for the Dutch Partners in Health (PIH) scale: 1) knowledge and coping; 2) recognition and management of symptoms, adherence to treatment. We recommend using these two subscale scores when assessing self-management in Dutch COPD patients.In summary, our implications for future research and clinical practice are: •consider the self-treatment of comorbidities in patient-tailored exacerbation action plans together with associated self-management training for patients with COPD and comorbidities;•cautiously only using action plans together with self-management interventions; •provide more detailed information regarding the delivered self-management intervention; •identify patient characteristics that predict successful COPD self-management; and •reach consensus on a final version of the Partners in Health scale.",
author = "Anke Lenferink",
note = "Because of copyright the open-access pdf has one chapter less.",
year = "2017",
month = "9",
day = "15",
language = "English",
isbn = "978-90-365-4373-6",
school = "University of Twente",

}

Self-management exacerbation action plans in patients with COPD and common comorbidities : the COPE-III study. / Lenferink, Anke .

2017. 260 p.

Research output: ThesisPhD Thesis - Research external, graduation UTAcademic

TY - THES

T1 - Self-management exacerbation action plans in patients with COPD and common comorbidities

T2 - the COPE-III study

AU - Lenferink, Anke

N1 - Because of copyright the open-access pdf has one chapter less.

PY - 2017/9/15

Y1 - 2017/9/15

N2 - Chronic Obstructive Pulmonary Disease (COPD) is a chronic progressive lung disease with distressing exacerbations - acute deteriorations in respiratory health - that contribute to impaired quality of life and increased hospitalisations, mortality and healthcare costs. Frequently existing comorbid conditions in COPD, such as cardiovascular diseases, mental health issues, and diabetes, have an important impact on disease severity, hospital admission rate, and survival. These comorbidities share common risk factors with COPD and have overlap in symptoms. In COPD patients with the added complexity of comorbidities a “one size fits all” approach that focuses solely on COPD symptoms may be inadequate and could lead to the initiation of incorrect or delayed treatment. Twenty-two studies were evaluated in a Cochrane review comparing the effectiveness of COPD self-management interventions including an action plan for acute exacerbations of COPD with usual care. We observed that self-management interventions including a COPD exacerbation action plan are associated with improvements in health-related quality of life and a lower probability of respiratory-related hospital admissions, without excess all-cause mortality. We report the design of the COPE-III self-management intervention, that combines self-initiated patient-tailored action plans for COPD and comorbidities (chronic heart failure, ischemic heart disease, anxiety, depression, diabetes mellitus) with ongoing case-manager support. We demonstrate that our international multicenter randomised controlled trial is the first to test and confirm that patients with COPD and important comorbidities have better outcomes if they receive a self-management intervention that addresses their multiple conditions compared to usual care. Furthermore, we found two subscales for the Dutch Partners in Health (PIH) scale: 1) knowledge and coping; 2) recognition and management of symptoms, adherence to treatment. We recommend using these two subscale scores when assessing self-management in Dutch COPD patients.In summary, our implications for future research and clinical practice are: •consider the self-treatment of comorbidities in patient-tailored exacerbation action plans together with associated self-management training for patients with COPD and comorbidities;•cautiously only using action plans together with self-management interventions; •provide more detailed information regarding the delivered self-management intervention; •identify patient characteristics that predict successful COPD self-management; and •reach consensus on a final version of the Partners in Health scale.

AB - Chronic Obstructive Pulmonary Disease (COPD) is a chronic progressive lung disease with distressing exacerbations - acute deteriorations in respiratory health - that contribute to impaired quality of life and increased hospitalisations, mortality and healthcare costs. Frequently existing comorbid conditions in COPD, such as cardiovascular diseases, mental health issues, and diabetes, have an important impact on disease severity, hospital admission rate, and survival. These comorbidities share common risk factors with COPD and have overlap in symptoms. In COPD patients with the added complexity of comorbidities a “one size fits all” approach that focuses solely on COPD symptoms may be inadequate and could lead to the initiation of incorrect or delayed treatment. Twenty-two studies were evaluated in a Cochrane review comparing the effectiveness of COPD self-management interventions including an action plan for acute exacerbations of COPD with usual care. We observed that self-management interventions including a COPD exacerbation action plan are associated with improvements in health-related quality of life and a lower probability of respiratory-related hospital admissions, without excess all-cause mortality. We report the design of the COPE-III self-management intervention, that combines self-initiated patient-tailored action plans for COPD and comorbidities (chronic heart failure, ischemic heart disease, anxiety, depression, diabetes mellitus) with ongoing case-manager support. We demonstrate that our international multicenter randomised controlled trial is the first to test and confirm that patients with COPD and important comorbidities have better outcomes if they receive a self-management intervention that addresses their multiple conditions compared to usual care. Furthermore, we found two subscales for the Dutch Partners in Health (PIH) scale: 1) knowledge and coping; 2) recognition and management of symptoms, adherence to treatment. We recommend using these two subscale scores when assessing self-management in Dutch COPD patients.In summary, our implications for future research and clinical practice are: •consider the self-treatment of comorbidities in patient-tailored exacerbation action plans together with associated self-management training for patients with COPD and comorbidities;•cautiously only using action plans together with self-management interventions; •provide more detailed information regarding the delivered self-management intervention; •identify patient characteristics that predict successful COPD self-management; and •reach consensus on a final version of the Partners in Health scale.

M3 - PhD Thesis - Research external, graduation UT

SN - 978-90-365-4373-6

ER -